Paragon Biosciences provides patients with important medicines by building innovative companies. The portfolio of companies encompassed by Paragon Biosciences are managed by biotech entrepreneurs and leaders in the healthcare sector. These individuals have made a commitment to deliver the best possible outcomes. The management and leadership team at Paragon Biosciences has a strong record. This includes receiving thirteen drug approvals from the FDA in the last decade. This rate of success is equal to much bigger companies. Their expertise is used for an acceleration of scientific breakthroughs and the financing and development of cutting edge biotech companies.
Jeff Aronin serves Paragon Biosciences as the CEO and Chairman. He has held these positions with the company since 2010. The company is a biopharmaceutical investment and global healthcare development firm. Jeff Aronin has additionally served numerous Paragon Biosciences portfolio companies as the Chairman including Harmony Biosciences, Castle Creek Pharmaceuticals and a biopharmaceutical company based on prescriptions and research.
Paragon Biosciences is about technology, scientific rigor, a strong commitment to all the patients served by the firm and discovery. They provide cutting edge resources and dedicated experts to all their portfolio companies. They connect their companies with clinical experts and entrepreneurs to provide the guidance, strategy and support necessary to make certain patients receive important medications (http://weeklyopinion.com/2018/03/jeff-aronin-improves-lives/). All phases of development, collaboration and clinical trials are conducted by the company with highly qualified medical experts. Paragon Biosciences applies efficiency and speed to ensure patients in need receive novel medications.
Jeff Aronin served Ovation Pharmaceuticals as the CEO and President from 2000 until 2009. Jeff Aronin was the founder of this biopharmaceutical company. Lundbeck acquired the company in 2009. Jeff Aronin continued to serve as CEO and President during the integration and acquisition of Ovation Pharmaceuticals. Jeff Aronin has gained vast experience as a CEO for numerous global biopharmaceutical companies. His skills include brand marketing, finances and strategic business development. His knowledge and leadership experience are valuable for the day to day management and operations of global corporations in an industry that is highly regulated. Jeff Aronin also has experience regarding executing and structuring acquisitions, mergers and corporate transactions.